NBEA基因变异相关癫痫性脑病1例并文献复习
Epileptic Encephalopathy Associated with NBEA Gene Mutation: A Case Report and Literature Review
DOI: 10.12677/acm.2025.15102950, PDF,    科研立项经费支持
作者: 滕新岭, 魏善英, 李秋波*:济宁医学院附属医院儿科,山东 济宁
关键词: NBEA基因癫痫性脑病儿童The NBEA Gene Epileptic Encephalopathy Children
摘要: 目的:探讨NBEA基因变异相关癫痫性脑病患儿的临床及遗传学特点。方法:回顾性分析1例NBEA基因变异相关癫痫性脑病患儿的病例资料,分析其临床表型及基因变异特点,并以“NBEA”“neurokeratin”“epilepsy”“epileptic encephalopathy”“癫痫”“癫痫性脑病”为关键词分别检索PubMed、中国知网、万方数据库,总结NBEA基因变异相关癫痫性脑病患儿的临床及遗传学特点。结果:患儿,男,1岁5个月,因“抽搐发作1月余”就诊,临床表现为肌阵挛发作、痉挛发作,发病前智力运动发育正常,癫痫发作后语言和运动发育明显倒退。家系全外显子组基因测序提示患儿NBEA基因杂合无义变异c.8398A>T(p.Lys2800*)。口服左乙拉西坦、托吡酯联合吡仑帕奈抗癫痫发作治疗后,癫痫发作控制,发育较前有进步。文献检索到5篇文献(1篇中文,4篇英文)共报道了24例(包含本例)NBEA基因变异相关癫痫性脑病患儿,多数患儿表现为难治性癫痫,均有不同程度的智力障碍/发育迟缓,语言发育迟滞明显,部分患儿合并孤独症谱系障碍。共发现24个变异位点,变异类型大多数为功能丧失变异。结论:NBEA基因变异相关癫痫性脑病预后不佳,对于难治性癫痫、发育迟缓(尤其是语言发育迟缓)、孤独症样表现的患儿,需警惕NBEA基因变异相关癫痫性脑病,进行基因检测有助于明确诊断。
Abstract: Objective: To investigate the clinical and genetic features of epileptic encephalopathy associated with NBEA gene variants. Methods: The clinical data of a child with epileptic encephalopathy associated with NBEA gene variation were retrospectively analyzed, and the characteristics of clinical phenotype and gene mutation were analyzed. “NBEA”, “neurokeratin”, “epilepsy”, “epileptic encephalopathy” and “epileptic encephalopathy” were used as keywords to search PubMed, CNKI and Wanfang database, respectively, to summarize the clinical and genetic features of epileptic encephalopathy associated with NBEA gene variants. Results: The boy, aged 1 year and 5 months, was admitted to the hospital due to myoclonic seizures and spasms for more than 1 month. His mental and motor development was normal before the onset of seizures, but his language and motor development regressed significantly after seizures. Whole exome sequencing revealed a heterozygous nonsense variant c.8398A>T(p.Lys2800*) in the NBEA gene. After oral administration of levetiracetam, topiramate and pirampanide, the seizures were controlled and the development was improved. Literature review identified 5 articles (1 in Chinese and 4 in English) that reported 24 cases of NBEA gene variants associated with epileptic encephalopathy (including this case). Most of the patients presented with intractable epilepsy, varying degrees of intellectual disability/developmental delay, with significant language delay, and some patients were complicated with autism spectrum disorder. A total of 24 variants were found, most of which were loss-of-function variants. Conclusions: NBEA gene variants associated with epileptic encephalopathy have a poor prognosis. Children with intractable epilepsy, developmental delay (especially language delay) and autism-like manifestations should be considered for NBEA gene variants associated with epileptic encephalopathy.
文章引用:滕新岭, 魏善英, 李秋波. NBEA基因变异相关癫痫性脑病1例并文献复习[J]. 临床医学进展, 2025, 15(10): 1815-1823. https://doi.org/10.12677/acm.2025.15102950

参考文献

[1] Niesmann, K., Breuer, D., Brockhaus, J., Born, G., Wolff, I., Reissner, C., et al. (2011) Dendritic Spine Formation and Synaptic Function Require Neurobeachin. Nature Communications, 2, Article No. 557. [Google Scholar] [CrossRef] [PubMed]
[2] Castermans, D., Volders, K., Crepel, A., Backx, L., De Vos, R., Freson, K., et al. (2010) SCAMP5, NBEA and AMISYN: Three Candidate Genes for Autism Involved in Secretion of Large Dense-Core Vesicles. Human Molecular Genetics, 19, 1368-1378. [Google Scholar] [CrossRef] [PubMed]
[3] Castermans, D. (2003) The Neurobeachin Gene Is Disrupted by a Translocation in a Patient with Idiopathic Autism. Journal of Medical Genetics, 40, 352-356. [Google Scholar] [CrossRef] [PubMed]
[4] Smith, M., Woodroffe, A., Smith, R., Holguin, S., Martinez, J., Filipek, P.A., et al. (2002) Molecular Genetic Delineation of a Deletion of Chromosome 13q12→q13 in a Patient with Autism and Auditory Processing Deficits. Cytogenetic and Genome Research, 98, 233-239. [Google Scholar] [CrossRef] [PubMed]
[5] Bowling, K.M., Thompson, M.L., Amaral, M.D., Finnila, C.R., Hiatt, S.M., Engel, K.L., et al. (2017) Genomic Diagnosis for Children with Intellectual Disability and/or Developmental Delay. Genome Medicine, 9, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
[6] Mulhern, M.S., Stumpel, C., Stong, N., Brunner, H.G., Bier, L., Lippa, N., et al. (2018) NBEA: Developmental Disease Gene with Early Generalized Epilepsy Phenotypes. Annals of Neurology, 84, 788-795. [Google Scholar] [CrossRef] [PubMed]
[7] Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., et al. (2015) Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405-424. [Google Scholar] [CrossRef] [PubMed]
[8] Boulin, T., Itani, O., El Mouridi, S., Leclercq-Blondel, A., Gendrel, M., Macnamara, E., et al. (2021) Functional Analysis of a De Novo Variant in the Neurodevelopment and Generalized Epilepsy Disease Gene NBEA. Molecular Genetics and Metabolism, 134, 195-202. [Google Scholar] [CrossRef] [PubMed]
[9] Schiavoni, S., Spagnoli, C., Rizzi, S., Salerno, G.G., Frattini, D., Pisani, F., et al. (2021) Beneficial Effects of the Ketogenic Diet on Drug-Resistant Epileptic Encephalopathy Associated with a de Novo NBEA Pathogenic Variant. Epileptic Disorders, 23, 739-743. [Google Scholar] [CrossRef] [PubMed]
[10] Pan, Z., Chen, C., Yin, F. and Peng, J. (2022) Genotypic and Phenotypic Spectra of NBEA-Related Neurodevelopmental Disorder with Epilepsy: A Case Series and Literature Review. World Journal of Pediatrics, 18, 636-641. [Google Scholar] [CrossRef] [PubMed]
[11] 刘文, 张勇, 胡湘蜀, 等. NBEA基因变异致发育性癫痫性脑病一例[J]. 癫痫杂志, 2023, 9(2): 168-172.
[12] Wang, X., Herberg, F.W., Laue, M.M., Wüllner, C., Hu, B., Petrasch-Parwez, E., et al. (2000) Neurobeachin: A Protein Kinase A-Anchoring, Beige/Chediak-Higashi Protein Homolog Implicated in Neuronal Membrane Traffic. The Journal of Neuroscience, 20, 8551-8565. [Google Scholar] [CrossRef] [PubMed]
[13] Cullinane, A.R., Schäffer, A.A. and Huizing, M. (2013) The Beach Is Hot: A LYST of Emerging Roles for Beach-Domain Containing Proteins in Human Disease. Traffic, 14, 749-766. [Google Scholar] [CrossRef] [PubMed]
[14] Nair, R., Lauks, J., Jung, S., Cooke, N.E., de Wit, H., Brose, N., et al. (2013) Neurobeachin Regulates Neurotransmitter Receptor Trafficking to Synapses. Journal of Cell Biology, 200, 61-80. [Google Scholar] [CrossRef] [PubMed]
[15] Miller, A.C., Voelker, L.H., Shah, A.N. and Moens, C.B. (2015) Neurobeachin Is Required Postsynaptically for Electrical and Chemical Synapse Formation. Current Biology, 25, 16-28. [Google Scholar] [CrossRef] [PubMed]
[16] Nuytens, K., Gantois, I., Stijnen, P., Iscru, E., Laeremans, A., Serneels, L., et al. (2013) Haploinsufficiency of the Autism Candidate Gene Neurobeachin Induces Autism-Like Behaviors and Affects Cellular and Molecular Processes of Synaptic Plasticity in Mice. Neurobiology of Disease, 51, 144-151. [Google Scholar] [CrossRef] [PubMed]
[17] Zoghbi, H.Y. and Bear, M.F. (2012) Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities. Cold Spring Harbor Perspectives in Biology, 4, a009886. [Google Scholar] [CrossRef] [PubMed]
[18] Fukata, Y. and Fukata, M. (2017) Epilepsy and Synaptic Proteins. Current Opinion in Neurobiology, 45, 1-8. [Google Scholar] [CrossRef] [PubMed]
[19] Youngson, N.A., Morris, M.J. and Ballard, J.W.O. (2017) The Mechanisms Mediating the Antiepileptic Effects of the Ketogenic Diet, and Potential Opportunities for Improvement with Metabolism-Altering Drugs. Seizure, 52, 15-19. [Google Scholar] [CrossRef] [PubMed]
[20] Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., et al. (2008) The Ketogenic Diet for the Treatment of Childhood Epilepsy: A Randomised Controlled Trial. The Lancet Neurology, 7, 500-506. [Google Scholar] [CrossRef] [PubMed]
[21] Sourbron, J., Klinkenberg, S., van Kuijk, S.M.J., Lagae, L., Lambrechts, D., Braakman, H.M.H., et al. (2020) Ketogenic Diet for the Treatment of Pediatric Epilepsy: Review and Meta-Analysis. Childs Nervous System, 36, 1099-1109. [Google Scholar] [CrossRef] [PubMed]
[22] Farzana, F., Zalm, R., Chen, N., Li, K.W., Grant, S.G.N., Smit, A.B., et al. (2016) Neurobeachin Regulates Glutamate-and Gaba-Receptor Targeting to Synapses via Distinct Pathways. Molecular Neurobiology, 53, 2112-2123. [Google Scholar] [CrossRef] [PubMed]
[23] Repetto, D., Brockhaus, J., Rhee, H.J., Lee, C., Kilimann, M.W., Rhee, J., et al. (2018) Molecular Dissection of Neurobeachin Function at Excitatory Synapses. Frontiers in Synaptic Neuroscience, 10, Article 28. [Google Scholar] [CrossRef] [PubMed]
[24] del Pino, I., Paarmann, I., Karas, M., Kilimann, M.W. and Betz, H. (2011) The Trafficking Proteins Vacuolar Protein Sorting 35 and Neurobeachin Interact with the Glycine Receptor β-Subunit. Biochemical and Biophysical Research Communications, 412, 435-440. [Google Scholar] [CrossRef] [PubMed]
[25] Nuytens, K., Tuand, K., Di Michele, M., Boonen, K., Waelkens, E., Freson, K., et al. (2013) Platelets of Mice Heterozygous for Neurobeachin, a Candidate Gene for Autism Spectrum Disorder, Display Protein Changes Related to Aberrant Protein Kinase A Activity. Molecular Autism, 4, Article No. 43. [Google Scholar] [CrossRef] [PubMed]